Anzeige
Mehr »
Samstag, 13.12.2025 - Börsentäglich über 12.000 News
Schock aus China - Lithium zieht an, Antimon wird politisch: Diese Aktie könnte 2026 durchstarten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrPaula Cobb steps down from Prothena's board to join Manifold Bio
FrGRI Bio closes $8 million public offering of common stock and warrants
FrParaZero showcases drone defense system to German delegation
FrKarbon Capital Partners raises $345 million in initial public offering
FrMarvell Technology declares $0.06 quarterly dividend
FrRalph Lauren declares quarterly dividend of $0.9125 per share
FrIM Cannabis appoints Asi Levi as new CFO
FrMonolithic Power Systems announces $1.56 quarterly dividend
FrSuntex Enterprises acquires Texas construction firm JA Development
FrMcGrath RentCorp declares quarterly dividend of $0.485 per share
FrUnitedHealth Group to release 2025 results, 2026 guidance in January
FrPower Metals signs cesium offtake with Albemarle, secures C$5 million
FrTether bids to acquire Italy's football giants Juventus FC
FrCourt approves Modivcare's bankruptcy reorganization plan
FrSouthwest Airlines to open crew base in Austin creating 2,000 jobs
FrPNC receives regulatory approvals for acquisition of FirstBank
FrOracle stock rating reiterated by Evercore ISI amid data center expansion
FrJiuzi Holdings secures $4 million through registered direct offering
FrPUCT approves Entergy Texas' Cypress to Legend transmission line
FrFirst Brands Group takes steps to stabilize operations amid restructuring
FrCQS New City High Yield Fund to issue 1 million shares at 51.1p
FrKestra Medical Technologies stock price target raised by Stifel to $30
FrH.C. Wainwright raises Arcus Biosciences stock price target to $32 on lower expenses
FrTruist Securities lowers Arcus Biosciences stock price target on trial failure
FrOxford Metrics chair Bullard purchases 37,316 shares